GO
Loading...

Celgene Corp

More

  • Final Glance: Biotechnology companies Wednesday, 1 Apr 2015 | 5:56 PM ET

    Amgen Inc. fell $2.75 or 1.7 percent, to $157.10. Biogen Idec fell $8.43 or 2.0 percent, to $413.81. Celgene Corp. fell$. 71 or. 6 percent, to $114.57.

  • Midday Glance: Biotechnology companies Wednesday, 1 Apr 2015 | 1:17 PM ET

    Amgen Inc. fell $3.88 or 2.4 percent, to $155.97. Biogen Idec fell $9.66 or 2.3 percent, to $412.58. Celgene Corp. fell $1.74 or 1.5 percent, to $113.54.

  • Early Glance: Biotechnology companies Wednesday, 1 Apr 2015 | 10:23 AM ET

    Amgen Inc. fell $4.57 or 2.9 percent, to $155.28. Biogen Idec fell $9.79 or 2.3 percent, to $412.45. Celgene Corp. fell $3.15 or 2.7 percent, to $112.13.

  • Final Glance: Biotechnology companies Tuesday, 31 Mar 2015 | 5:58 PM ET

    Amgen Inc. fell $4.46 or 2.7 percent, to $159.85. Biogen Idec fell $9.38 or 2.2 percent, to $422.24. Celgene Corp. fell $4.74 or 3.9 percent, to $115.28.

  • Midday Glance: Biotechnology companies Tuesday, 31 Mar 2015 | 2:47 PM ET

    Amgen Inc. fell $3.17 or 1.9 percent, to $161.14. Biogen Idec fell $1.75 or. 4 percent, to $429.87. Celgene Corp. fell $3.90 or 3.2 percent, to $116.12.

  • Early Glance: Biotechnology companies Tuesday, 31 Mar 2015 | 10:29 AM ET

    Amgen Inc. fell $2.29 or 1.4 percent, to $162.02. Biogen Idec fell $2.62 or. 6 percent, to $429.00. Celgene Corp. fell $2.41 or 2.0 percent, to $117.61.

  • The stock market closed out the first three months of the year Tuesday on a down note, erasing much of the gains from the prior day's big rally. The Dow Jones industrial average slumped 200 points, knocking the blue chip index slightly lower for the year. The Standard& Poor's 500 index ended the quarter with a meager gain of half a percent.

  • Final Glance: Biotechnology companies Monday, 30 Mar 2015 | 5:56 PM ET

    Amgen Inc. rose $1.72 or 1.1 percent, to $164.31. Biogen Idec rose $1.75 or. 4 percent, to $431.62. Celgene Corp. rose $1.34 or 1.1 percent, to $120.02.

  • Midday Glance: Biotechnology companies Monday, 30 Mar 2015 | 1:16 PM ET

    Amgen Inc. rose$. 93 or. 6 percent, to $163.52. Biogen Idec rose $2.22 or. 5 percent, to $432.09. Celgene Corp. rose$. 83 or. 7 percent, to $119.51.

  • Early Glance: Biotechnology companies Monday, 30 Mar 2015 | 10:56 AM ET

    Amgen Inc. rose $2.54 or 1.6 percent, to $165.13. Biogen Idec rose $4.55 or 1.1 percent, to $434.42. Celgene Corp. rose $1.49 or 1.3 percent, to $120.17.

  • Final Glance: Biotechnology companies Friday, 27 Mar 2015 | 6:10 PM ET

    Amgen Inc. rose $2.04 or 1.3 percent, to $162.59. Biogen Idec rose$. 94 or. 2 percent, to $429.87. Celgene Corp. rose $1.02 or. 9 percent, to $118.68.

  • Midday Glance: Biotechnology companies Friday, 27 Mar 2015 | 1:16 PM ET

    Amgen Inc. rose $2.20 or 1.4 percent, to $162.75. Biogen Idec rose $6.16 or 1.4 percent, to $435.09. Celgene Corp. rose $1.66 or 1.4 percent, to $119.32.

  • Final Glance: Biotechnology companies Thursday, 26 Mar 2015 | 6:07 PM ET

    Amgen Inc. fell$. 07 or percent, to $160.55. Biogen Idec fell $2.70 or. 6 percent, to $428.93. Celgene Corp. rose$. 67 or. 6 percent, to $117.66.

  • Midday Glance: Biotechnology companies Thursday, 26 Mar 2015 | 2:20 PM ET

    Amgen Inc. rose$. 17 or. 1 percent, to $160.79. Biogen Idec fell $3.13 or. 7 percent, to $428.51. Celgene Corp. rose$. 85 or. 7 percent, to $117.84.

  • Early Glance: Biotechnology companies Thursday, 26 Mar 2015 | 10:34 AM ET

    Amgen Inc. rose$. 38 or. 2 percent, to $161.00. Biogen Idec fell $6.27 or 1.5 percent, to $425.36. Celgene Corp. rose $1.13 or 1.0 percent, to $118.12.

  • Final Glance: Biotechnology companies Wednesday, 25 Mar 2015 | 6:03 PM ET

    Amgen Inc. fell $5.39 or 3.2 percent, to $160.62. Biogen Idec fell $21.08 or 4.7 percent, to $431.63. Celgene Corp. fell $5.16 or 4.2 percent, to $116.99.

  • Midday Glance: Biotechnology companies Wednesday, 25 Mar 2015 | 1:43 PM ET

    Amgen Inc. fell $3.89 or 2.3 percent, to $162.13. Biogen Idec fell $19.26 or 4.3 percent, to $433.45. Celgene Corp. fell $3.99 or 3.3 percent, to $118.16.

  • Early Glance: Biotechnology companies Wednesday, 25 Mar 2015 | 11:55 AM ET

    Amgen Inc. fell $2.19 or 1.3 percent, to $163.83. Biogen Idec fell $11.90 or 2.6 percent, to $440.81. Celgene Corp. fell $1.58 or 1.3 percent, to $120.57.

  • Science, patients driving rare disease drug research surge Wednesday, 25 Mar 2015 | 10:38 AM ET

    TRENTON, N.J.— The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits. The investments come as researchers harness recent scientific advances, including the mapping of...

  • Final Glance: Biotechnology companies Tuesday, 24 Mar 2015 | 8:17 PM ET

    Amgen Inc. fell$. 53 or. 3 percent, to $166.01. Biogen Idec fell $11.02 or 2.4 percent, to $452.71. Celgene Corp. fell$. 79 or. 6 percent, to $122.15.